BARD1 and breast cancer genetic predisposition: case–control study and HRD signature analysis

Breast Cancer · Published 2026-07-24 · DOI 10.1007/s12282-026-01898-5

Authors (46)

Marie-Florence Reveneau, Antoine De Pauw, Julien Masliah-Planchon, Antoine Decees, Salma Lakhlifi, Justine Pasanisi, Jessica Le Gall, Mathias Schwartz, Mélanie Pagès, Elise Pierre-Noël, Molka Sebai, Sandrine M. Caputo, Virginie Moncoutier, Henrique Tenreiro, Christelle Berthemin, Jennifer Carrière, Catherine Dubois d’Enghien, Khadija Abidallah, Christophe Guy, Nicolas Fort, Narjes Zaguia, Anaïs Curto Taribo, Olfa Trabelsi Grati, Leslie Lori, Arnaud Maillard, Camille Benoist, Eleonore Frouin, Kévin Merchadou, Fabien Quinquis, Mathilde Filser, Hélène Delhomelle, Marine Le Mentec, Mathilde Warcoin, Ophélie Bertrand, Marie-Charlotte Villy, Claire Saule, Emmanuelle Mouret-Fourme, Marion Gauthier-Villars, Bruno Buecher, Tatiana Popova, Marc-Henri Stern, Victor Renault, Eric Pasmant, Dominique Stoppa-Lyonnet, Chrystelle Colas, Lisa Golmard

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Reveneau, M., Pauw, A., Masliah-Planchon, J., et al. (2026). BARD1 and breast cancer genetic predisposition: case–control study and HRD signature analysis. Breast Cancer. https://doi.org/10.1007/s12282-026-01898-5

Related articles

• Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology · Genetics in Medicine · 2015 · Cites or is cited by this article
• Three cases of whole breast irradiation for breast cancer in patients with Lymphangioleiomyomatosis (LAM) · Breast Cancer · 2026 · Same journal
• Low protein, high risk: hypoalbuminemia predicts adverse outcomes after mastectomy in 37,848 breast cancer patients · Breast Cancer · 2026 · Same journal
• BRCA1/2 Reversion Mutations in Japanese Patients with Metastatic Breast Cancer Progressing on Olaparib: OLIVE (WJOG15321B) · Breast Cancer · 2026 · Same journal
• Fear of diagnosis as a barrier to the screening and diagnosis of breast cancer · Breast Cancer · 2026 · Same journal
• Quality of life in women with breast cancer undergoing chemotherapy: a comparative cross-sectional study of CICC ports and PICC-ports · Breast Cancer · 2026 · Same journal
• Characteristics of a multigene assay (MammaPrint/Blueprint) to predict early recurrence of hormone receptor-positive, HER2-negative breast cancer: a case‒control study (WJOG16722B) · Breast Cancer · 2026 · Same journal
• Limits of substitution and context-dependent selective omission of Oncotype DX recurrence score testing · Breast Cancer · 2026 · Same journal
• Breast ultrasound screening in young adult women undergoing infertility treatment at an infertility clinic: a retrospective observational study · Breast Cancer · 2026 · Same journal
• Minimal important differences of EORTC QLQ-C30 and QLQ-BR23 for metastatic breast cancer patients in a Japanese population: results from the RESQ trial · Breast Cancer · 2026 · Same journal